The Securities and Exchange Commission (SEC) has clarified its regulatory stance, establishing that activist investors are now required to disclose the identities of their clients within official filings. This updated interpretation is set to impact how hedge funds and activist firms approach their interactions with target companies.
This regulatory shift brings to mind the corporate tensions observed in 2022, specifically the conflict involving the medical device manufacturer Masimo Corp. During that period, Masimo Corp faced pressure from the activist firm Politan Capital. In response to the proxy battle, Masimo Corp amended its corporate bylaws to mandate that any activist investor planning to nominate directors must publicly disclose the identities of the fund’s limited partners. Additionally, the company required activists to reveal any intentions to nominate candidates for director positions at other firms.
